Long-Term Safety and Effectiveness of Roflumilast Cream 0.3% in Adults With Chronic Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: a 52-week, phase 2, open-label trial
J Am Acad Dermatol 2024 Mar 29;[EPub Ahead of Print], L Stein Gold, DN Adam, L Albrecht, J Alonso-Llamazares, LK Ferris, MJ Gooderham, HC Hong, SE Kempers, LH Kircik, M Lebwohl, WJ Loo, WK Nahm, KA Papp, D Stewart, DP Toth, M Zirwas, D Krupa, S Snyder, P Burnett, R Higham, DR BerkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.